Thus, CGA, in combination with anti-PD-1 antibody, could either enhance anticancer immunity of the infiltrated CD8+ T cells (via inhibiting PD-L1 expression in tumor) or accelerate tumor cell cytolysis (by enhancing T cell granzymes expression). The gene discussed is CD8A; the disease is neoplasm.